Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1261473
Disease: Sarcoma
Sarcoma
0.070 Biomarker group BEFREE <sup>18</sup>F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue Sarcomas. 30926647 2019
CUI: C1261473
Disease: Sarcoma
Sarcoma
0.070 Biomarker group BEFREE Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas. 30196378 2019
CUI: C1261473
Disease: Sarcoma
Sarcoma
0.070 Biomarker group BEFREE The role of 18F-FDG PET/CT in soft tissue sarcoma. 30908341 2019
CUI: C1261473
Disease: Sarcoma
Sarcoma
0.070 Biomarker group BEFREE Significant correlations between pyruvate-to-lactate rate constants and <sup>18</sup>F-FDG uptake were found for sarcoma patients, whereas no significant correlations appeared for carcinoma patients. 29803387 2018
CUI: C1261473
Disease: Sarcoma
Sarcoma
0.070 Biomarker group BEFREE Use of 18F-FDG-PET/CT for Retroperitoneal/Intra-Abdominal Soft Tissue Sarcomas. 30065620 2018
CUI: C1261473
Disease: Sarcoma
Sarcoma
0.070 GeneticVariation group BEFREE Prognostic value of 18F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis. 28178131 2017
CUI: C1261473
Disease: Sarcoma
Sarcoma
0.070 Biomarker group BEFREE This work arises from consideration of sarcoma patients in which fluorodeoxyglucose positron emission tomography (FDG-PET) imaging pre-therapy and post-chemotherapy is used to assess treatment response. 27990685 2017